Artera Announces Two Presentations at ASTRO 2024 Validating its MMAI Platform to Inform Treatment Decisions for Oligometastatic Castration-Sensitive Prostate Cancer (omCSPC)
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present [...]
MedCity Pivot Podcast: How AI Can Help in Cancer
Dr. Timothy Showalter talks about how AI can be a powerful force in recommending treatment for cancer patients. He is Artera' [...]
Artera Launches AI Test for Decision-making on Prostate Cancer Treatment Course
Artera, the Los Altos, California-based developer of tools to diagnose cancer, has launched the first artificial intelligence [...]
Unlocking the Global Potential of Precision Medicine with AI
While the US has been a leader in precision medicine for cancer research and healthcare innovation, countries around the worl [...]
What My Patients Have Taught Me During Their Cancer Journeys
As a radiation oncologist, I have the privilege of walking alongside my patients through their cancer journeys. While I certa [...]
How AI Can Help Alleviate the Stress of a Cancer Diagnosis
In an era where cancer rates continue to rise, the emotional toll a cancer diagnosis and the subsequent treatment journey has [...]
ASCO 2024: Randomized PROSTATE-IQ Trial to Reduce ADT Treatment Burden for Patients with Biochemical Recurrence After Prostatectomy
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 31st and June 4th, 2024 [...]
Artera Announces Three Presentations at ASCO 2024 That Demonstrate the Reliability and Depth of its AI Cancer Platform
Artera, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, will present three [...]
How can Artera bootstrap a new AWS region within hours?
Setting up the infrastructure for a product line in an entirely new region with over 340 distinct AWS resources could easily [...]